Ezetimibe monotherapy secondary prevention
WebFor people taking ezetimibe monotherapy (if statins are contraindicated or not tolerated), consider ezetimibe with bempedoic acid if ezetimibe alone does not control low-density … WebAug 1, 2015 · Background: Little is known concerning the effect of ezetimibe for secondary prevention in post-myocardial infarction (MI) patients. In this study, we investigated the secondary prevention effect of ezetimibe for post-MI patients. Methods: This study is a retrospective analysis of Assessing Lipophilic vs. hydrophilic Statin therapy for Acute MI …
Ezetimibe monotherapy secondary prevention
Did you know?
WebJul 20, 2024 · Some of the more common side effects that can occur with use of ezetimibe include: diarrhea. stuffy nose. viral infection of your nose, throat, and airways. joint pain. … Web3 to about 24%.11 In the IMPROVE-IT trial including >18,000 patients with recent acute coronary syndrome, combination therapy of ezetimibe and simvastatin resulted in significant reduction in the primary study endpoint compared with simvastatin monotherapy.11 Moreover, the addition of ezetimibe to atorvastatin resulted in greater coronary plaque …
WebMay 20, 2024 · The study will include patients receiving lipid-lowering therapy in both primary and secondary prevention of CVD who have received therapy of interest for ≥ 3 months in the 2 years preceding the signing of informed consent, i.e. statins as monotherapy or in combination with ezetimibe in a stable mode (without dose … WebMay 4, 2024 · Objective To compare the impact of ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on cardiovascular outcomes in adults taking maximally tolerated statin therapy or who are statin intolerant. Design Network meta-analysis. Data sources Medline, EMBASE, and Cochrane Library up to 31 December …
WebApr 12, 2024 · Primary endpoint rates did not differ between the combo group (moderate-intensity statin plus ezetimibe) or the monotherapy group (high-intensity statin … WebApr 12, 2024 · Primary endpoint rates did not differ between the combo group (moderate-intensity statin plus ezetimibe) or the monotherapy group (high-intensity statin monotherapy group). For patients aged ≥75 years, the primary outcome rates were 10.6% for the combination group and 12.3% for the monotherapy group (hazard ratio [HR], …
WebNov 17, 2014 · A. Adding ezetimibe, a non-statin agent, to statin therapy reduces cardiovascular events in high-risk patients with acute coronary syndrome (ACS), according to results of the IMPROVE-IT Trial presented Nov. 17 at AHA 2014. The study was led by Christopher P. Cannon, MD, FACC, professor of medicine at Harvard Medical School …
Webcholesterol (LDL-C) as a means of either secondary or primary prevention of cardiovascular disease. Statins are the first-line therapy for pharmacological lipid … diy home theater decorWebJun 2, 2024 · The goal blood pressure for most stroke patients with hypertension is <130/80 mm Hg. In most stroke patients, atorvastatin 80 mg daily is recommended to … diy home theater equipment rackWebWhen patients were stratified by age and clinical risk using the TIMI Risk Score for Secondary Prevention 22 (TRS 2°P) (Figure 3B), it was evident that, compared with simvastatin monotherapy, simvastatin-ezetimibe … diy home theater decor ideacraigslist seattle cars for saleWebApr 20, 2024 · statins + ezetimibe) Secondary prevention: NR: Weintraub et al., 40 2024: USA: 64 (median) with icosapent ethyl 64 (median) with standard care ... Adding ER-ERN/LRPT to statin was cost-effective compared to statin monotherapy in the secondary prevention of CHD among T2DM patients over a lifetime horizon. 33 The study also … craigslist seattle backpageWebEzetimibe is used together with lifestyle changes (diet, weight-loss, exercise) to reduce the amount of cholesterol (a fat-like substance) and other fatty substances in the blood. It … craigslist seattle car and truck by ownerWebSep 26, 2024 · In atherosclerotic stroke, lipid-lowering treatment with a target LDL (low-density lipoprotein) cholesterol of <70 compared with 100±10 mg/dL reduced the risk of subsequent cardiovascular events. This post hoc analysis explored the relative effects of the combination of statin and ezetimibe (dual therapy) and statin monotherapy in achieving ... craigslist seattle apartments greenwood